Completed PHASE4 INTERVENTIONAL 2-arm NCT03393572

Intraperitoneal Bupivacaine With Magnesium or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy

Intraperitoneal Instillation of Bupivacaine With Either Magnesium Sulphate or Nalbuphine for Postoperative Pain Control in Laparoscopic Hysterectomy: a Prospective, Randomized, Double-blinded Trial.

Sponsor: Ain Shams University

Conditions Anesthesia

Interventions Bupivacaine 0.25% Magnesium sulphate. nalbuphine

Updated 6 times since 2018 Last updated: Jul 13, 2019 Started: Jan 3, 2018 Primary completion: Jun 5, 2018 Completion: Jun 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03393572, this PHASE4 trial focuses on Anesthesia and remains completed. Sponsored by Ain Shams University, it has been updated 6 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Aug 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Jun 2018 — Aug 2019 [monthly]

Active Not Recruiting PHASE4

▶ Show 1 earlier version

Jan 2018 — Jun 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt